Clinical Trials Logo

Filter by:
NCT ID: NCT06041815 Recruiting - Clinical trials for Hematological Malignancies

Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies

Start date: September 3, 2023
Phase:
Study type: Observational

The purpose of this prospective and observational study is to evaluate the correlation between gut microbiota and clinical response to CAR-T treatment for hematological malignancies

NCT ID: NCT06041776 Recruiting - Clinical trials for Non-Small Cell Lung Cancer

Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations

Start date: March 28, 2023
Phase: Phase 3
Study type: Interventional

This multicenter, randomized, controlled, double-blind, double-simulated, Phase III study is designed to evaluate the efficacy and safety of Befotertinib compared with Icotinib as adjuvant treatment in EGFR-sensitive mutation-positive stage IB-IIIB (T3N2M0) non-small cell lung cancer after surgical resection.

NCT ID: NCT06041659 Recruiting - Moyamoya Disease Clinical Trials

Functional Magnetic Resonance-Based Observations of Brain Networks in Moyamoya Disease Patients Under Anesthesia

Start date: October 24, 2023
Phase:
Study type: Observational

Moyamoya disease is characterized by progressive stenosis of the genesis of the distal internal carotid arteries bilaterally and progressive generation of compensatory pathological vascular networks at the basis cranii, and these pathological vasculature has poor vascular reactivity. Perioperative circulatory management of patients with smoky vessels to ensure perfusion of brain tissue and integrity of brain network during surgery to minimize postoperative impairment of neurological functions, including motor, sensory, emotional and cognitive functions, is the key point of perioperative circulatory management of moyamoya disease. Functional Magnetic Resonance Imaging (fMRI) has been routinely used in various cerebrovascular diseases to further evaluate cerebrovascular reserve and cerebral network connectivity. The purpose of this study is to observe the changes in cerebral blood flow, cerebral oxygen metabolism, cerebral oxygen metabolism rate, and cerebral network connectivity in adult patients with moyamoya disease in cerebral ischemia-sensitive areas under anesthesia to provide a basis for exploring anesthesia management to improve cognitive function and cerebral network connectivity in these patients.

NCT ID: NCT06041620 Recruiting - Thalassemia Major Clinical Trials

Safety and Efficacy Evaluation of Autologous CRISPR-Cas12b Edited Hematopoietic Stem Cells

Start date: August 31, 2023
Phase: N/A
Study type: Interventional

This is a single-arm, open, single-injection exploratory clinical study with two transfusion-dependent β thalassemia (β-TDT) participants planned to enroll.

NCT ID: NCT06041477 Recruiting - Clinical trials for Hepatocellular Carcinoma

Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC

HAIC
Start date: September 2023
Phase: Phase 3
Study type: Interventional

The goal of this clinical trial is to compare HAIC concurrently with sequentially combined with targeted and immunotherapies in terms of efficacy and safety in patients with potentially resectable intermediate and advanced HCC (CNLC stage IIa~IIIa). The main questions it aims to answer are: - Does a "strong combination" regimen of three simultaneous treatments (HAIC, targeted agents and immunotherapy) definitely result in a higher surgical conversion rate and better survival benefit? - Can the combination of targeted and immunotherapies based on patients' response to HAIC therapy avoid over-treatment of some patients without affecting the surgical conversion rate and overall survival? Participants will be randomly assigned to receive either HAIC concurrently or sequentially combined with targeted and immunotherapies. Researchers will compare concurrent treatment group with sequential treatment group to see if there are different in terms of the conversion resection rate, long-term survival, and safety.

NCT ID: NCT06041451 Recruiting - Clinical trials for Guillain-Barre Syndrome

Early and Late Prognosis in Patients With Guillain-Barre Syndrome

Start date: January 2, 2013
Phase: Phase 4
Study type: Interventional

The goal of this observational study is to explore significant indicators to predict the early prognosis and late prognosis in patients with Guillain-Barre syndrome.

NCT ID: NCT06041412 Recruiting - Clinical trials for Diabetic Peripheral Neuropathy

The Effect of Related Blood Markers on Diabetic Peripheral Neuropathy

Start date: February 1, 2012
Phase:
Study type: Observational

The goal of this observational study is to explore the relationship between related blood indicators and diabetic peripheral neuropathy(DPN).

NCT ID: NCT06041399 Recruiting - Clinical trials for Diabetic Peripheral Neuropathy

The Effect of Related Blood Markers on Diabetic Peripheral Neuropathy

Start date: February 1, 2012
Phase: Phase 4
Study type: Interventional

The goal of this observational study is to explore the relationship between related blood indicators and diabetic peripheral neuropathy.

NCT ID: NCT06041282 Recruiting - Adhesive Capsulitis Clinical Trials

Conservative Treatment of Early Adhesive Capsulitis

Start date: October 30, 2023
Phase: N/A
Study type: Interventional

A prospective, multicentre, randomized controlled study comparing the efficacy of conservative treatment for early adhesive capsulitis

NCT ID: NCT06041217 Recruiting - Obesity Clinical Trials

A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range

STEP12
Start date: September 15, 2023
Phase: Phase 3
Study type: Interventional

This study will look at how the investigational dose of semaglutide works in helping people with excess body weight, to lose weight. This study will compare the weight loss in people taking semaglutide to people taking "dummy" medicine (placebo). The study will last for about 1 year. The participants will have 12 visits at the clinic and 3 remote visits by phone calls with the study doctor or staff.